Skip to content
  • Home
  • Book Bag: 0 items (Full)
    • English
    • 日本語
    • 中文(简体)
    • 中文(繁體)
    • اللغة العربية
  • About
Advanced
  • 1312 Identification and valida...
  • Cite this
  • Text this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Add to Book Bag Remove from Book Bag
  • Permanent link

1312 Identification and validation of immunogenic clonal neoantigens for personalized therapies

Bibliographic Details
Published in:Journal for ImmunoTherapy of Cancer
Main Authors: Andrew Craig, Martin Forster, Samra Turajlic, Sergio A Quezada, Katy Newton, Karl Peggs, Fong Chan, Karen Matthews, Theres Oakes, Gareth Wilson, Elizabeth Larose Cadieux, Max Salm, Hugh O’Brien
Format: Article
Language:English
Published: BMJ Publishing Group 2023-11-01
  • Holdings
  • Description
  • Similar Items
  • Staff View

Similar Items

  • 437 Optimised achilles VELOSTM process 2b manufacturing platform generates a significant dose boost of reactive CD8 and CD4 clonal neoantigen-reactive T cells for the treatment of solid cancer
    by: Sergio A Quezada, et al.
    Published: (2023-11-01)
  • The clonal hydra: neoantigen-specific T-cell response in germ cell tumors
    by: Shefali Mehra, et al.
    Published: (2024-01-01)
  • Profiling immunogenic neoantigen peptides elicited by personalized neoantigen vaccine in cancer patients
    by: Peng Zhao, et al.
    Published: (2026-06-01)
  • Inverse relationship between neoantigen clonality and T-cell activity reveals distinct immune phenotypes in HNSCC
    by: Babak Saravi, et al.
    Published: (2026-06-01)
  • Compromised function in the Nav1.2 Dravet syndrome mutation R1312T
    by: Christoph Lossin, et al.
    Published: (2012-09-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs